Claude Évin (born 29 June 1949) is a French politician and lawyer.
|French Minister of Social Affairs|
|Prime Minister||Michel Rocard|
|Preceded by||Michèle Barzach|
|Succeeded by||Jean-Louis Bianco|
|Born||29 June 1949|
Le Cellier, France
|Political party||Socialist Party|
He was first elected in 1978. Prior to becoming a Member of Parliament, Claude Evin was the deputy mayor of Saint-Nazaire, a post he held until 1989. In his lengthy career, he held a variety of positions including Vice President of the National Assembly (1986–87); Minister for Health (1988–91) and Minister for Social Affairs (1988–91). As Minister for Health, he proposed the French alcohol and tobacco policy law, now known as Loi Evin, to the parliament (Law 91-32 of 10 January 1991).
He is notable for mandating the drug company Roussel Uclaf to resume the distribution of mifepristone, an abortifactant, two days after the company's board voted 16-4 to discontinue its distribution due to concerns of the image of the company's majority-owner. This was regarding a negative public image related to the popular anti-abortion sentiments of France in the late 1980s. He stated "I could not permit the abortion debate to deprive women of a product that represents medical progress. From the moment government approval for the drug was granted, RU-486 became the moral property of women, not just the property of a drug company."
- "Assemblée nationale ~ Les députés : M. Claude Evin". French Assemblée nationale.
- Baulieu, Étienne-Émile; Rosenblum, Mort (1991). The "abortion pill" : RU-486, a woman's choice. New York: Simon & Schuster. ISBN 0-671-73816-X.
Lader, Lawrence (1991). RU 486 : the pill that could end the abortion wars and why American women don't have it. Reading: Addison-Wesley. ISBN 0-201-57069-6.
Villaran, Gilda (1998). "RU 486". In Schlegelmilch, Bodo B. (ed.). Marketing ethics : an international perspective. London: Thomson Learning. pp. 155–190. ISBN 1-86152-191-X.
Ulmann, André (2000). "The development of mifepristone: a pharmaceutical drama in three acts". J Am Med Womens Assoc. 55 (3 Suppl): 117–20. PMID 10846319.